首页> 外文会议>Postgraduate Course in Critical Care Medicine >Efficacy of non-invasive positive pressure ventilation in acute cardiogenic pulmonary oedema
【24h】

Efficacy of non-invasive positive pressure ventilation in acute cardiogenic pulmonary oedema

机译:非侵入性正压通气在急性心肌肺水肿中的功效

获取原文

摘要

Non-invasive positive pressure ventilation (NIPPV), administered via a nasal or full-face mask, is now a well-documented modality of ventilatory assistance to avoid endotracheal intubation in selected patients with acute respiratory failure (ARF) . Preservation of airway defence mechanisms and speech, complete avoidance of trauma to oropharynx, larynx, and trachea, reduction in ventilator-associated pneumonia (VAP) , and reduction in length of stay (LOS) are the main advantages over conventional invasive ventilation. However NIPPV has potential limitations, including the lack of direct access to the airway for removal of secretions, facial trauma related to a mask, and need for patient co-operation. NIPPV using bilevel positive airway pressure (BiPAP), via nasal or full-face mask, has been shown to improve arterial blood gas (ABG), decrease intensive care unit (ICU) LOS and complication rates, and improve patient survival. In majority of trials with BiPAP, the major patient group enrolled was ARF due to exacerbation of chronic obstructive pulmonary disease (COPD). Many researchers, such as Meduri et al. Kramer et al., and Popnick et al. have included a few patients with acute cardiogenic pulmonary edema (ACPE) presenting as ARF in their studies, and have reported improvement in clinical and ABG status of this subset of patients. Although a few studies on the utility of continuous positive airway pressure (CPAP) in ACPE have been performed in the past, very few studies have been published on the efficacy of BiPAP in ACPE . Mehta et al. compared BiPAP and CPAP in their trial, and concluded that BiPAP improves ventilation and vital signs more rapidly than CPAP in patients with ACPE. One of the largest studies is by Hoffman and Welte from Germany. In an open, prospective, uncontrolled trial in patients with ACPE in ARF, they reported successful avoidance of intubation in 28 of 29 patients, with significant improvement in PCO_2, pH, and oxygen saturation.
机译:通过鼻腔或全面罩施用的非侵入性正压通风(NIPPV)现在是一种良好的通风辅助方式,以避免选定患者的急性呼吸衰竭(ARF)中的气管内插管。保存气道防御机制和言语,完全避免创伤,喉头,喉和气管,减少呼吸机相关的肺炎(VAP)和逗留时间(LOS)是传统侵入式通风的主要优势。然而,Nippv具有潜在的限制,包括缺乏对气道的直接进入,以便去除分泌物,面部创伤与面具相关,需要患者合作。通过鼻腔或全面掩模,利用贝迪尔正气道压力(BIPAP),已被证明改善动脉血液(ABG),减少重症监护单位(ICU)LOS和并发症率,并改善患者存活率。在BIPAP的大部分试验中,由于慢性阻塞性肺病(COPD)的加剧,主要患者群是ARF。许多研究人员,如Meduri等。 kramer等人,和popnick等人。含有少数患有急性心胸性肺水肿(ACPE)的患者在其研究中呈现为ARF,并报告了这种患者临床和ABG状态的改善。虽然过去已经进行了关于ACPE中连续正气道压力(CPAP)的效用的一些研究,但在ACPE中的BIPAP疗效上发表了很少的研究。 Mehta等人。比较BIPAP和CPAP在他们的试验中,并得出结论,BIPAP比ACPE患者的CPAP更快地改善通风和生命症状。最大的研究之一是来自德国的Hoffman和Welte。在ARF患者的患者中,在ACPE患者中,他们报告了29例患者中的28例,在28例患者中成功避免了插管,PCO_2,pH和氧饱和度显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号